Immunic to Participate in Investor and Scientific Conferences in May

NEW YORK, May 6, 2024 /PRNewswire/ -- Immunic, Inc. , a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and...

Related Keywords

Washington ,United States ,Ohio ,Ukraine ,Cleveland ,Sofia ,Sofiya Grad ,Bulgaria ,Russia ,Spain ,Jessica Breu ,Edna Kaplan ,Paula Schwartz ,Sonya Ivanova Hristova Chakmakova ,Robertj Fox ,Franziska Buri ,Exchange Commission ,Nasdaq ,Mellen Center ,Research Forum ,National Congress ,Neurological Institute ,Rx Communications Group ,Consortium Of Multiple Sclerosis Centers ,Immunic Inc ,Vice President Investor Relations ,San Sebasti ,Digestive Disease Week ,Senior Medical Director ,Sliced Bread ,Multiple Sclerosis Centers ,Staff Neurologist ,Multiple Sclerosis ,Cleveland Clinic ,Vidofludimus Calcium ,Serum Neurofilament ,Session Date ,Session Time ,Assistant Professor ,Multiprofile Hospital ,Active Treatment ,Golden Sands ,Serum Neurofilament Light Chain ,Progressive Multiple Sclerosis ,Interim Data ,Private Securities Litigation Reform Act ,Middle East ,Annual Report ,President Investor Relations ,Communications Group ,Markets ,